1-17 of 17
William D. Travis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset

Christopher A. Febres-Aldana, Jason C. Chang, Ryan Ptashkin, Yuhan Wang, Erika Gedvilaite, Marina K. Baine, William D. Travis, Katia Ventura, Francis Bodd, Helena A. Yu, Alvaro Quintanal-Villalonga, W. Victoria Lai, Jacklynn V. Egger, Michael Offin, Marc Ladanyi, Charles M. Rudin, Natasha Rekhtman
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (21): 4702–4713.
https://doi.org/10.1158/1078-0432.CCR-22-1115
Published: 01 November 2022
View article titled, Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset
Open the PDF for Rb Tumor Suppressor in Small Cell Lung Cancer: Combined Genomic and IHC Analysis with a Description of a Distinct Rb-Proficient Subset in another window
Includes: Supplementary data
Journal Articles

Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity

Kathryn M. Tully, Salomon Tendler, Lukas M. Carter, Sai Kiran Sharma, Zachary V. Samuels, Komal Mandleywala, Joshua A. Korsen, Avelyn Mae Delos Reyes, Alessandra Piersigilli, William D. Travis, Triparna Sen, Nagavarakishore Pillarsetty, John T. Poirier, Charles M. Rudin, Jason S. Lewis
Journal: Clinical Cancer Research
Clin Cancer Res (2022) 28 (7): 1391–1401.
https://doi.org/10.1158/1078-0432.CCR-21-1533
Published: 01 April 2022
View article titled, Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity
Open the PDF for Radioimmunotherapy Targeting Delta-like Ligand 3 in Small Cell Lung Cancer Exhibits Antitumor Efficacy with Low Toxicity in another window
Includes: Supplementary data
Journal Articles

Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes

Jason C. Chang, Michael Offin, Christina Falcon, David Brown, Brian R. Houck-Loomis, Fanli Meng, Vasilisa A. Rudneva, Helen H. Won, Sharon Amir, Joseph Montecalvo, Patrice Desmeules, Kyuichi Kadota, Prasad S. Adusumilli, Valerie W. Rusch, Sarah Teed, Joshua K. Sabari, Ryma Benayed, Khedoudja Nafa, Laetitia Borsu, Bob T. Li, Alison M. Schram, Maria E. Arcila, William D. Travis, Marc Ladanyi, Alexander Drilon, Natasha Rekhtman
Journal: Clinical Cancer Research
Clin Cancer Res (2021) 27 (14): 4066–4076.
https://doi.org/10.1158/1078-0432.CCR-21-0423
Published: 15 July 2021
View article titled, Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes
Open the PDF for Comprehensive Molecular and Clinicopathologic Analysis of 200 Pulmonary Invasive Mucinous Adenocarcinomas Identifies Distinct Characteristics of Molecular Subtypes in another window
Includes: Supplementary data
Journal Articles

Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach

Jason C. Chang, Deepu Alex, Matthew Bott, Kay See Tan, Venkatraman Seshan, Andrew Golden, Jennifer L. Sauter, Darren J. Buonocore, Chad M. Vanderbilt, Sounak Gupta, Patrice Desmeules, Francis M. Bodd, Gregory J. Riely, Valerie W. Rusch, David R. Jones, Maria E. Arcila, William D. Travis, Marc Ladanyi, Natasha Rekhtman
Journal: Clinical Cancer Research
Clin Cancer Res (2019) 25 (23): 7113–7125.
https://doi.org/10.1158/1078-0432.CCR-19-1700
Published: 02 December 2019
View article titled, Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach
Open the PDF for Comprehensive Next-Generation Sequencing Unambiguously Distinguishes Separate Primary Lung Carcinomas From Intrapulmonary Metastases: Comparison with Standard Histopathologic Approach in another window
Includes: Supplementary data
Journal Articles

An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer

Luc Girard, Jaime Rodriguez-Canales, Carmen Behrens, Debrah M. Thompson, Ihab W. Botros, Hao Tang, Yang Xie, Natasha Rekhtman, William D. Travis, Ignacio I. Wistuba, John D. Minna, Adi F. Gazdar
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (19): 4880–4889.
https://doi.org/10.1158/1078-0432.CCR-15-2900
Published: 02 October 2016
View article titled, An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer
Open the PDF for An Expression Signature as an Aid to the Histologic Classification of Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets

Natasha Rekhtman, Maria C. Pietanza, Matthew D. Hellmann, Jarushka Naidoo, Arshi Arora, Helen Won, Darragh F. Halpenny, Hangjun Wang, Shaozhou K. Tian, Anya M. Litvak, Paul K. Paik, Alexander E. Drilon, Nicholas Socci, John T. Poirier, Ronglai Shen, Michael F. Berger, Andre L. Moreira, William D. Travis, Charles M. Rudin, Marc Ladanyi
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (14): 3618–3629.
https://doi.org/10.1158/1078-0432.CCR-15-2946
Published: 14 July 2016
View article titled, Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets
Open the PDF for Next-Generation Sequencing of Pulmonary Large Cell Neuroendocrine Carcinoma Reveals Small Cell Carcinoma–like and Non–Small Cell Carcinoma–like Subsets in another window
Includes: Supplementary data
Journal Articles

Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma

Stefan S. Kachala, Adam J. Bograd, Jonathan Villena-Vargas, Kei Suzuki, Elliot L. Servais, Kyuichi Kadota, Joanne Chou, Camelia S. Sima, Eva Vertes, Valerie W. Rusch, William D. Travis, Michel Sadelain, Prasad S. Adusumilli
Journal: Clinical Cancer Research
Clin Cancer Res (2014) 20 (4): 1020–1028.
https://doi.org/10.1158/1078-0432.CCR-13-1862
Published: 16 February 2014
View article titled, Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma
Open the PDF for Mesothelin Overexpression Is a Marker of Tumor Aggressiveness and Is Associated with Reduced Recurrence-Free and Overall Survival in Early-Stage Lung Adenocarcinoma in another window
Includes: Supplementary data
Journal Articles

Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of EGFR/KRAS and Presence of PIK3CA/AKT1 Mutations

Natasha Rekhtman, Paul K. Paik, Maria E. Arcila, Laura J. Tafe, Geoffrey R. Oxnard, Andre L. Moreira, William D. Travis, Maureen F. Zakowski, Mark G. Kris, Marc Ladanyi
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (4): 1167–1176.
https://doi.org/10.1158/1078-0432.CCR-11-2109
Published: 14 February 2012
View article titled, Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of <em>EGFR</em>/<em>KRA</em>S and Presence of <em>PIK3CA</em>/<em>AKT1</em> Mutations
Open the PDF for Clarifying the Spectrum of Driver Oncogene Mutations in Biomarker-Verified Squamous Carcinoma of Lung: Lack of <em>EGFR</em>/<em>KRA</em>S and Presence of <em>PIK3CA</em>/<em>AKT1</em> Mutations in another window
Includes: Supplementary data
Journal Articles

Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker

M. Catherine Pietanza, Kyuichi Kadota, Kety Huberman, Camelia S. Sima, John J. Fiore, Dyana K. Sumner, William D. Travis, Adriana Heguy, Michelle S. Ginsberg, Andrei I. Holodny, Timothy A. Chan, Naiyer A. Rizvi, Christopher G. Azzoli, Gregory J. Riely, Mark G. Kris, Lee M. Krug
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (4): 1138–1145.
https://doi.org/10.1158/1078-0432.CCR-11-2059
Published: 14 February 2012
View article titled, Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker
Open the PDF for Phase II Trial of Temozolomide in Patients with Relapsed Sensitive or Refractory Small Cell Lung Cancer, with Assessment of Methylguanine-DNA Methyltransferase as a Potential Biomarker in another window
Includes: Supplementary data
Journal Articles

Abstract A13: Lung Adenocarcinoma Subtypes Based on the Expression of Airway Basal Cell Genes

Tomoya Fukui, Renat Shaykhiev, Neil R. Hackett, Robert J. Downey, William D. Travis, Ronald G. Crystal
Journal: Clinical Cancer Research
Clin Cancer Res (2012) 18 (3_Supplement): A13.
https://doi.org/10.1158/1078-0432.12AACRIASLC-A13
Published: 01 February 2012
View article titled, Abstract A13: Lung Adenocarcinoma Subtypes Based on the Expression of Airway Basal Cell Genes
Open the PDF for Abstract A13: Lung Adenocarcinoma Subtypes Based on the Expression of Airway Basal Cell Genes in another window
Journal Articles

Prognostic Immune Markers in Non–Small Cell Lung Cancer

Kei Suzuki, Stefan S. Kachala, Kyuichi Kadota, Ronglai Shen, Qianxing Mo, David G. Beer, Valerie W. Rusch, William D. Travis, Prasad S. Adusumilli
Journal: Clinical Cancer Research
Clin Cancer Res (2011) 17 (16): 5247–5256.
https://doi.org/10.1158/1078-0432.CCR-10-2805
Published: 14 August 2011
View article titled, Prognostic Immune Markers in Non–Small Cell Lung Cancer
Open the PDF for Prognostic Immune Markers in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer

Akihiko Yoshizawa, Junya Fukuoka, Shigeki Shimizu, Konstantin Shilo, Teri J. Franks, Stephen M. Hewitt, Takeshi Fujii, Carlos Cordon-Cardo, Jin Jen, William D. Travis
Journal: Clinical Cancer Research
Clin Cancer Res (2010) 16 (1): 240–248.
https://doi.org/10.1158/1078-0432.CCR-09-0986
Published: 04 January 2010
View article titled, Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer
Open the PDF for Overexpression of Phospho-eIF4E Is Associated with Survival through AKT Pathway in Non–Small Cell Lung Cancer in another window
Includes: Supplementary data
Journal Articles

Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas

Nicolas Girard, Ronglai Shen, Tianhua Guo, Maureen F. Zakowski, Adriana Heguy, Gregory J. Riely, James Huang, Christopher Lau, Alex E. Lash, Marc Ladanyi, Agnes Viale, Cristina R. Antonescu, William D. Travis, Valerie W. Rusch, Mark G. Kris, William Pao
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (22): 6790–6799.
https://doi.org/10.1158/1078-0432.CCR-09-0644
Published: 11 November 2009
View article titled, Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas
Open the PDF for Comprehensive Genomic Analysis Reveals Clinically Relevant Molecular Distinctions between Thymic Carcinomas and Thymomas in another window
Includes: Supplementary data
Journal Articles

Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers

Nicolas Girard, Irina Ostrovnaya, Christopher Lau, Bernard Park, Marc Ladanyi, David Finley, Charuhas Deshpande, Valerie Rusch, Irene Orlow, William D. Travis, William Pao, Colin B. Begg
Journal: Clinical Cancer Research
Clin Cancer Res (2009) 15 (16): 5184–5190.
https://doi.org/10.1158/1078-0432.CCR-09-0594
Published: 12 August 2009
View article titled, Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers
Open the PDF for Genomic and Mutational Profiling to Assess Clonal Relationships Between Multiple Non–Small Cell Lung Cancers in another window
Includes: Supplementary data
Journal Articles

Prognostic Implications of Molecular and Immunohistochemical Profiles of the Rb and p53 Cell Cycle Regulatory Pathways in Primary Non–Small Cell Lung Carcinoma

Louise Burke, Douglas B. Flieder, Donald G. Guinee, Elizabeth Brambilla, Andrew N. Freedman, William P. Bennett, Raymond T. Jones, Andrew Borkowski, Neil A. Caporaso, Marian Fleming, Victor Trastek, Peter Pairolero, Henry Tazelaar, David Midthun, James R. Jett, Lance A. Liotta, William D. Travis, Curtis C. Harris
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (1): 232–241.
https://doi.org/10.1158/1078-0432.232.11.1
Published: 21 January 2005
View article titled, Prognostic Implications of Molecular and Immunohistochemical Profiles of the Rb and p53 Cell Cycle Regulatory Pathways in Primary Non–Small Cell Lung Carcinoma
Open the PDF for Prognostic Implications of Molecular and Immunohistochemical Profiles of the Rb and p53 Cell Cycle Regulatory Pathways in Primary Non–Small Cell Lung Carcinoma in another window
Includes: Supplementary data
Journal Articles

Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer

Junya Fukuoka, Takeshi Fujii, Joanna H. Shih, Tatiana Dracheva, Daoud Meerzaman, Audrey Player, Kyeong Hong, Sharon Settnek, Ajay Gupta, Kenneth Buetow, Stephen Hewitt, William D. Travis, Jin Jen
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (13): 4314–4324.
https://doi.org/10.1158/1078-0432.CCR-03-0489
Published: 06 July 2004
View article titled, Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer
Open the PDF for Chromatin Remodeling Factors and BRM/BRG1 Expression as Prognostic Indicators in Non-Small Cell Lung Cancer in another window
Journal Articles

Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma

Aizen J. Marrogi, William D. Travis, Judith A. Welsh, Mohammed A. Khan, Haress Rahim, Henry Tazelaar, Peter Pairolero, Victor Trastek, James Jett, Neil E. Caporaso, Lance A. Liotta, Curtis C. Harris
Journal: Clinical Cancer Research
Clin Cancer Res (2000) 6 (12): 4739–4744.
Published: 01 December 2000
View article titled, Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma
Open the PDF for Nitric Oxide Synthase, Cyclooxygenase 2, and Vascular Endothelial Growth Factor in the Angiogenesis of Non-Small Cell Lung Carcinoma in another window